21 May 2013
Keywords: summit, signs, zebrafish, platform, deal, uk, biotechnology
Article | 20 October 2008
UK biotechnology company Summit has signed a non-exclusive research agreement with US health care giant Johnson & Johnson to explore and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2008
20 May 2013
© 2013 thepharmaletter.com